Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Workit Health Study Demonstrates High Retention In Rural Patients Receiving Telemedicine For Opioid Use Disorder


News provided by

Workit Health

May 22, 2023, 08:00 ET

Share this article

Share toX

Share this article

Share toX


Workit Health Publishes Positive Telemedicine Outcomes for Opioid Use Disorder in the Largest Sample of US Rural Patients to Date

ANN ARBOR, Mich., May 22, 2023 /PRNewswire-PRWeb/ -- Workit Labs, the research arm of Workit Health, the nation's leading provider of virtual substance use disorder treatment, is pleased to announce the publication of a groundbreaking study in the peer-reviewed journal Telemedicine and E-Health. This study represents the largest sample to date of American patients living in rural areas and receiving telemedicine for opioid use disorder. The findings demonstrate that telemedicine is an effective solution for rural populations living with opioid use disorder, addressing the challenges of accessibility and retention in treatment.

The peer-reviewed study, titled "Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations: A Retrospective Cohort Study," underscores the success of telemedicine in delivering treatment for opioid use disorder to individuals residing in rural communities. Lead author Marlene Lira, MPH, highlights the significance of the findings, stating, "Our study provides compelling evidence that telemedicine-delivered treatment for opioid use disorder is remarkably effective in retaining patients in rural areas, revolutionizing addiction treatment across the country. As the DEA considers the necessity of in-person visits for buprenorphine prescriptions, our findings highlight the immense value and convenience of telemedicine in providing accessible evidence-based care without in-person visits."

Our study provides compelling evidence that telemedicine-delivered treatment for opioid use disorder is remarkably effective in retaining patients in rural areas, revolutionizing addiction treatment across the country.

Post this

The study encompassed a cohort of over 1,800 rural patients from 14 states across the United States, providing a broad view of the impact of telemedicine on opioid use disorder treatment outcomes. Patients had an average age of 37 years and nearly two-thirds were insured by Medicaid. The findings revealed exceptional retention rates among patients engaged in telemedicine-delivered treatment, surpassing or aligning with retention rates reported in traditional in-person settings. Notably, over half of the patients remained in care at the six-month mark, an improvement from previous studies utilizing claims and discharge data for in-person treatment, which reported retention rates ranging from 35% to 41%.

The study also shed light on the high adherence to buprenorphine treatment within the telemedicine-delivered model. An impressive 90% of retained patients completed urine drug screens at each time point, and among those who participated, an overwhelming 99% displayed positive results for buprenorphine. These findings underscore the robust adherence to buprenorphine treatment among patients receiving telemedicine-delivered care, alleviating concerns regarding diversion and reinforcing the efficacy and integrity of the treatment approach.

The results of this study not only demonstrate the effectiveness of telemedicine in retaining patients and improving treatment outcomes in rural areas but also highlight the positive impact of telemedicine on buprenorphine adherence, mitigating potential concerns surrounding diversion. By embracing telemedicine as a powerful tool in delivering evidence-based care, Workit Health continues to pioneer innovative solutions that ensure equitable access to comprehensive addiction treatment, benefiting individuals and communities nationwide.

Dr. Justin Coffey, Chief Medical Officer of Workit Health and senior author of the study emphasizes the potential of telemedicine in transforming addiction treatment for rural communities, stating, "The burden of drug use and overdose is tragically heavy in rural communities. Safe and effective treatment for opioid use disorder exists, but accessing that treatment is unacceptably difficult. Our findings demonstrate how Workit's 'patients as designers' approach can result in dramatic and sustained reductions in harm from opioids, even in some of the hardest hit areas of rural America."

Workit Health's telemedicine-delivered treatment platform combines evidence-based practices with convenient, virtual care, enabling patients to access comprehensive addiction treatment from the comfort of their homes. The study's findings support the growing body of research that demonstrates the efficacy of telemedicine in expanding treatment access and improving patient outcomes.

For more information on the study and Workit Health's innovative telemedicine-delivered treatment for opioid use disorder, please visit https://www.workithealth.com.

About Workit Health:
Founded in 2015 by two women in recovery, Workit Health has been addressing substance use disorders using a virtual-first model for eight years. The Workit clinical program includes video visits with licensed clinicians, e-prescribing for substance use disorders and comorbid conditions, and psychosocial, and therapeutic support. Workit's innovative technology removes barriers and expands access to evidence-based, person-centered treatment for people struggling with drugs and alcohol, improving outcomes while reducing costs.

Media Contact

Kali Lux, Workit Health, 1 602-698-6181, [email protected]

LinkedIn

SOURCE Workit Health

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.